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To determine the origin of the virus associated with a 
measles outbreak in Menglian County, Yunnan Province, 
People’s Republic of China, in 2009, we conducted genetic 
analyses. Phylogenetic analyses based on nucleoprotein (N) 
and hemagglutinin (H) gene sequences showed that these 
Menglian viruses were not closely related to sequences of 
any World Health Organization (WHO) reference strains rep-
resenting the 23 currently recognized genotypes. The mini-
mum nucleotide divergence between the Menglian viruses 
and the most closely related reference strain, genotype D7, 
was 3.3% for the N gene and 3.0% for the H gene. A search 
of the databases of GenBank, WHO, and the Health Protec-
tion Agency Measles Nucleotide Surveillance showed that 
the Menglian viruses, together with the 2 older non-Mengli-
an viruses, could be members of a new proposed measles 
genotype, d11. The new genotype designation will allow for 
better description of measles transmission patterns, espe-
cially in the Southeast Asian and Western Paciﬁ  c regions.
M
easles virus is a negative-sense, single-stranded RNA 
virus in the family Paramyxoviridae, genus Morbil-
livirus. Infection with this virus typically causes high fever, 
maculopapular rash, conjunctivitis, cough, and coryza (1). 
Measles virus is monotypic, but genetic variation in the he-
magglutinin (H) and nucleoprotein (N) genes can be ana-
lyzed by molecular epidemiologic techniques and used to 
study virus transmission patterns (2–4). The World Health 
Organization (WHO) currently recognizes 23 genotypes of 
measles virus and has established guidelines for the desig-
nation of new genotypes (3–7).
Although deaths attributed to measles have declined 
by 78% worldwide, from ≈733,000 deaths in 2000 to 
≈164,000 in 2008, risk for illness and death from measles 
still exists in countries with poor routine vaccination cov-
erage, and outbreaks are a threat in most of these countries 
(6,8). When the Universal Childhood Immunization goals 
were attained in the 1990s, illness and death from measles 
in the People’s Republic of China decreased dramatically. 
During 1995–2009, measles incidence was 5–10/100,000 
population, and <250 measles-associated deaths were re-
ported each year (9–11; National Notiﬁ  able Disease Re-
porting System of China [http://202.106.123.35/]). Out-
breaks of measles continued to occur because of increased 
numbers of susceptible children, especially in areas with 
low routine vaccination coverage. At the end of 2009, a 
measles outbreak in Menglian County was reported to the 
National Measles Laboratory of the Chinese Center for 
Disease Control and Prevention. Menglian County is situ-
ated on the western side of Yunnan Province and shares a 
border with Myanmar. As part of routine surveillance ac-
tivities, the measles outbreak was investigated. Cases were 
conﬁ  rmed through detection of immunoglobulin (Ig) M, 
and virus isolates were obtained for genetic analysis.
Materials and Methods
Specimen Collection
Staff members from the Yunnan Center for Disease 
Control and Prevention collected serum and throat swab or 
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urine specimens from patients during the outbreak (14 from 
Myanmar and 16 from Menglian). Serum samples were 
collected from 9 Myanmar and 7 Menglian case-patients. 
Throat swabs or urine specimens, from the ﬁ  rst 6 Menglian 
patients, were obtained according to the WHO procedures 
for laboratory diagnoses of measles and rubella virus infec-
tions (12) and transported to the National Measles Labo-
ratory for processing by standard procedures. To conﬁ  rm 
all suspected cases, we used ELISA kits (Virion/Serion 
GmbH, Würzburg, Germany) to detect measles and rubella 
virus IgM. 
Virus Isolation, PCR, and Sequencing
Measles virus was isolated by using the Vero/hSLAM 
cell line (13), and infected cells were harvested when >75% 
of the culture showed cytopathic effect (12). Meanwhile, 
RNA was extracted from all clinical specimens by using 
the QIAamp Viral RNA Mini Kit (QIAGEN, Beijing, 
China) according to manufacturer’s instructions. Reverse 
transcription–PCR (RT-PCR) was used to amplify either 
the 550 nt coding for the COOH terminus of the N gene 
or the full-length open reading frame for the H gene (14). 
PCR products were puriﬁ  ed by using a QIAquick Gel Ex-
traction kit (QIAGEN). Sequences of the amplicons were 
obtained by using BigDye terminator version 2.0 chemistry 
according to the manufacturer’s protocol for both sense and 
antisense strands on an automated ABI PRISMTM 3100 
DNA Sequencer (PerkinElmer, Beijing, China). Sequences 
were analyzed by using SequencerTM (Gene Codes Cor-
poration, Ann Arbor, MI, USA) and version 7.0 of BioEdit 
(www.mbio.ncsu.edu/BioEdit/BioEdit.html). Phylogenetic 
analyses were performed and trees were generated by using 
MEGA4 (www.megasoftware.net). The robustness of the 
groupings was assessed by using bootstrap resampling of 
1,000 replicates.
Results
During 2008–2009, routine measles vaccine cover-
age in Menglian County was as high as 95%; the last local 
measles case before this outbreak had been reported in June 
2008. The outbreak began when 14 persons from Myan-
mar became ill with fever and rash and sought healthcare in 
Menglian during October 10–November 28, 2009. The ﬁ  rst 
measles case in a person from Menglian occurred on No-
vember 5, 2009; the last occurred on December 20. On De-
cember 28, the number of measles cases from the outbreak 
totaled 14 persons from Myanmar and 16 from Menglian. 
Measles was conﬁ  rmed by laboratory detection of IgM in 
all 16 patients from whom serum samples were available 
(9 from Myanmar and 7 from Menglian). No IgM against 
rubella virus was detected (Table 1).
Two measles virus isolates, MVi/Menglian.Yunnan.
CHN/47.09 and MVi/Menglian.Yunnan.CHN/51.09, were 
obtained from urine and throat swab specimens of 2 per-
sons from Menglian. Positive RT-PCR products of the 
partial N gene were obtained from clinical specimens from 
5 of 6 case-patients, and the entire H gene was ampliﬁ  ed 
from the 2 isolates (Table 2). The sequence of the 450 
nucleotides coding for the 150 amino acids at the COOH 
terminus of the N gene was obtained for all 5 case-patients, 
and the entire coding region of the H gene was sequenced 
for 1 representative isolate. Nucleotide sequence data for 
the strains from the Menglian case-patients were deposited 
in GenBank under accession nos. GU440571–GU440576. 
Sequence analysis of the C-terminal 450 nucleotides of the 
N gene of 2 isolates and 5 clinical specimens revealed iden-
tical sequences, suggesting a single chain of transmission. 
Phylogenetic and genetic distance analyses based on both 
N and H gene sequences showed that these viruses from 
Menglian case-patients were members of clade D (Figures 
1, 2; Table 3). 
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Table 1. Characteristics of patients with laboratory-confirmed measles, 2009* 
Patient no.  Patient age  Residence† Date of most recent vaccination  Date of disease onset  
1 9 y Myanmar Unknown  Nov 4
2 9 y Myanmar Unknown  Nov 4
3 8 y Myanmar Unknown  Nov 4
4 7 y Myanmar Unknown  Nov 6
5 2 y Myanmar Unknown  Nov 3
6 2 y Menglian Unknown Nov 9
7 39 y Menglian Unknown Nov 9
8 21 y Menglian Unknown Nov 5
9 18 mo  Myanmar  Unknown  Nov 13 
10 6 mo  Menglian No vaccination  Nov 14 
11 13 y Myanmar Unknown  Nov 6
12 8 y  Myanmar  No vaccination  Nov 22 
13 20 y  Myanmar  No vaccination  Nov 20 
14 2 y  Menglian 2008 Jan15  Nov 19 
15 5 y  Menglian 2006 Jun 7  Dec 9 
16 5 y  Menglian 2008 Oct 27  Nov 5 
*For all patients, immunoglobulin M against measles virus was positive and against rubella virus was negative. 
†Menglian, Menglian County, Yunnan Province, People’s Republic of China. New Measles Virus Genotype
The sequences of these viruses were not closely related 
to the sequences of any of the WHO reference strains that 
represented the 23 currently recognized genotypes. These 
sequences were closest to the sequence of the genotype D7 
reference strain and the contemporary genotype D7 strains 
available from GenBank. The minimum nucleotide diver-
gence between the Menglian viruses and the D7 WHO 
reference strain (Victoria.AUS/16.85) was 3.3% for the N 
gene and 3.0% for the H gene (Table 3). Bootstrap analysis 
of Menglian H-gene sequences and the WHO reference se-
quences showed 100% conﬁ  dence in the group containing 
the Menglian viruses. When the N-gene sequences were 
compared with WHO reference sequences and contem-
porary genotype D7 sequences, bootstrap support for the 
Menglian branch was 100% (Figure 1).
A search of the databases of GenBank, WHO, and the 
Health Protection Agency Measles Nucleotide Surveillance 
(www.who-measles.org) identiﬁ   ed only 2 closely related 
sequences. The most closely related sequence was from a 
measles virus isolate, MVi/WA.AUS/12.01 (GenBank ac-
cession no. AF481492), previously designated as genotype 
D7, which had been imported from Myanmar into Australia 
in 2001 (15). The second, from a clinical specimen, MVs/
Uvbridge.GBR/19.04 (GenBank accession no. GU937234), 
was detected in an oral ﬂ  uid sample collected in 2004 from 
a person who had recently returned to the United Kingdom 
from Bangladesh. Both of these related sequences shared 
98.4% nucleotide homology with the Menglian virus over the 
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Table 2. Description of measles viruses, proposed genotype d11, detected in Menglian County, Yunnan Province, People’s Republic
of China, 2009 
Patient no.  Patient age 
Result, by test 
Strain name  GenBank accession no.  RT-PCR Virus  isolation 
YN09–1 6 mo + + MVi/Menglian.Yunnan.CHN/47.09  GU440571,†  GU440576‡ 
YN09–2 45 y + – MVs/Menglian.Yunnan.CHN/47.09/1 GU440572† 
YN09–3 21 y + – MVs/Menglian.Yunnan.CHN/47.09/2 GU440573† 
YN09–4 6 mo + + MVi/Menglian.Yunnan.CHN/51.09  GU440574† 
YN09–5 5 y + – MVs/Menglian.Yunnan.CHN/51.09 GU440575† 
*RT-PCR, reverse transcription–PCR; MVi, measles virus sequence from isolates; MVs, measles virus sequence from clinical specimens. 
†Sequence of N partial gene. 
‡Sequence of H gene. 
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Figure 1. Phylogenetic analysis of the sequences of the 
nucleoprotein genes (450 nt) of the strains of measles virus from 
Menglian County, Yunnan Province, People’s Republic of China. 
The unrooted tree shows sequences from Menglian viruses (circles) 
compared with World Health Organization (WHO) reference 
strains for each genotype. Triangles indicate D7 WHO reference 
strains; diamonds, the 2 older non-Menglian strains. Genotype 
designation is in boldface. MV, measles virus; MVi, measles virus 
sequence from isolates; MVs, measles virus sequence from clinical 
specimens. Scale bar indicates base substitutions per site.
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Figure 2. Phylogenetic analysis of the sequences of the 
hemagglutinin genes of the strains of measles virus from Menglian 
County, Yunnan Province, People’s Republic of China. The 
unrooted tree shows sequences from the Menglian viruses (circles) 
compared with World Health Organization reference strains for 
each genotype. Genotype designation is in boldface. MVi, measles 
virus sequence from isolates; MV, measles virus; MVs, measles 
virus sequence from clinical specimens; wt, wild type. Scale bar 
indicates base substitutions per site.RESEARCH
450 nucleotides coding for the 150 amino acids at the COOH 
terminus of the N gene. Phylogenetic analysis showed that 
the 2 older non-Menglian strains (MVi/WA.AUS/12.01 and 
MVs/Uvbridge.GBR/19.04) formed a unique cluster com-
bined with 5 Menglian strains (Figure 1).
Discussion
The Menglian measles viruses, together with the 2 
closely related viruses, MVi/WA.AUS/12.01 and MVs/
Uvbridge.GBR/19.04, should be considered as mem-
bers of a newly proposed measles genotype, d11. MVi/
Menglian.Yunnan.CHN/47.09 (GenBank accession nos.: 
N, GU440571; H, GU440576) was chosen as the reference 
strain because an isolate is available, it grows to high ti-
ter in cell culture, and the sequence is representative of the 
Menglian strains. Although designation as a genotype is not 
permanent until after the new genotype has been acknowl-
edged and formally designated by WHO, the percentage 
sequence divergence between the N and H gene sequences 
of the Menglian isolates and the sequences of the reference 
strains exceed the recommended threshold for designation 
of a new measles genotype, 2.5% and 2.0%, respectively 
(3–5). Phylogenetic analyses indicated that these viruses 
form a unique cluster compared with all previously char-
acterized wild-type measles viruses. Because the Australia 
virus was imported from Myanmar and the sequence from 
the United Kingdom originated in a country adjacent to 
Myanmar, these sequences should be included as members 
of the proposed d11 genotype.
The most useful criterion for a new genotype is that 
it must have some epidemiologic utility for describing the 
transmission pathways of measles virus. The Menglian vi-
ruses responsible for the measles outbreak in China rep-
resent strains that are probably associated with endemic 
transmission of virus in Myanmar. When we consider the 
sequence of the Australia virus, we believe that the geno-
type d11 measles virus might have been circulating in 
Myanmar since 2001. The d11 sequences are easily distin-
guished from the sequences of viruses in other genotypes 
(e.g., D8, D4, H1, D5, D9, G3) that are circulating in neigh-
boring countries. Therefore, the Menglian viruses are pro-
viding baseline genetic information about viruses endemic 
to Myanmar and possibly neighboring countries. The new 
genotype designation will enable better description of 
measles transmission patterns, especially in the Southeast 
Asian and Western Paciﬁ  c regions of WHO.
Molecular epidemiologic data, when analyzed in con-
junction with standard epidemiologic data, can help docu-
ment viral transmission pathways, identify whether a vi-
rus is endemic or imported, and aid in case classiﬁ  cation, 
thus enhancing control and elimination programs (16–20). 
Genetic characterization of measles viruses circulating in 
China from 1993 through 2009 demonstrated that geno-
type H1 was widely distributed throughout the country and 
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Table 3. Genetic distances between proposed reference strain for genotype d11 (MVi/Menglian.Yunnan.CHN/47.09) and reference 
strains* 
WHO reference strain, genotype: virus name 
Genotype d11, % nucleotide divergence 
Nucleoprotein gene  Hemagglutinin gene 
A: Edmonston-wt.USA/54  5.8 3.7
B1:Yaounde.CAE/12.83 7.3 4.7
B2: Libreville.GAB/84  7.8 5.6
B3: New York.USA/94  7.1 5.2
C1: Tokyo.JPN/84/K  6.0 3.9
C2: Maryland.USA/77  7.8 4.4
D1: Bristol.UNK/74  4.4 4.0
D2: Johannesburg.SOA/88/1  4.4 4.6
D3: Illinois.USA/89/1  4.2 3.7
D4: Montreal.CAN/89  4.7 3.0
D5: Palau.BLA/93  3.8 3.5
D6: New Jersey.USA/94/1  5.8 4.2
D7: Victoria.AUS/16.85  3.3 3.0
D8: Manchester.UNK/30.94  4.4 3.0
D9: Victoria.AUS/12.99  4.9 3.5
D10: Kampala.UGA/51.00/1  7.3 4.3
E: Goettingen.DEU/71  6.4 4.5
F: MVs/Madrid.SPA/94 SSPE  6.4 4.4
G1: Berkeley.USA/83  8.0 5.2
G2: Amsterdam.NET/49.97  8.7 5.8
G3: Gresik.INO/17.02  7.6 6.3
H1: Hunan.CHN/93/7  7.6 6.6
H2: Beijing.CHN/94/1  9.1 5.7
*WHO, World Health Organization; CAE, Cameroon; GAB, Gabon; JPN, Japan; UNK, United Kingdom; SOA, South Africa; CAN, Canada; AUS, Australia; 
UGA, Uganda; DEU, Germany; SPA, Spain; NET, the Netherlands; INO, Indonesia; CHN, China. New Measles Virus Genotype
that China has a single, endemic genotype (9–11; National 
Measles Laboratory database, unpub. data) However, data 
on the circulating genotypes in some other countries in the 
Southeast Asian and Western Paciﬁ  c regions of WHO are 
limited. Further sequence analysis of measles virus strains 
circulating in Myanmar and neighboring countries should 
clarify the distribution pattern of this newly recognized 
genotype and may enable recognition of other new geno-
types. Countries in the Western Paciﬁ  c Region, includ-
ing China, have committed to 2012 as the target year for 
measles elimination (21). However, rapidly identifying 
imported measles cases and controlling spread are major 
challenges for achieving this goal. Enhancing measles virus 
surveillance to quickly identify imported cases of measles 
will become more critical as measles elimination goals are 
achieved throughout the world.
Acknowledgments
We thank the Yunnan provincial, prefectural, and county staff 
members who collected the clinical specimens for this study.
This study was supported by the Key Technologies Re-
search and Development Program of the National Ministry of 
Science (grant nos. 2009ZX10004-201, 2009ZX10004-202, and 
2008ZX10004-014-5) from China and the grants from the WHO 
fund for the Western Paciﬁ  c Regional Ofﬁ  ce of the Measles Re-
gional Reference Laboratory.
Dr Zhang is an associate researcher at the National Institute 
for Viral Disease Control and Prevention, Chinese Center for Dis-
ease Control and Prevention. Her major research interests are the 
epidemiology and molecular biology of respiratory viruses.
References
  1.   Grifﬁ  n DE. Measles virus. 4th ed. Philadelphia: Lippincott Williams 
and Wilkins; 2001.
  2.   Rota PA, Rota JS, Bellini WJ. Molecular epidemiology of measles 
virus. Seminars in Virology. 1995;6:379–86. DOI: 10.1016/S1044-
5773(05)80015-0
  3.   World Health Organization. Nomenclature for describing the genetic 
characteristics of wild-type measles viruses (update). Part 2. Wkly 
Epidemiol Rec. 2001;76:249–51. 
  4.   World Health Organization. Nomenclature for describing the genetic 
characteristics of wild-type measles viruses (update). Part 1. Wkly 
Epidemiol Rec. 2001;76:241–7.
  5.   World Health Organization. Update of the nomenclature for describ-
ing the genetic characteristics of wild-type measles viruses: new 
genotypes and reference strains. Wkly Epidemiol Rec. 2003;78:229–
32.
  6.   World Health Organization. Global measles and rubella laboratory 
network–update. Wkly Epidemiol Rec. 2005;80:384–8.
  7.   World Health Organization. New genotype of measles virus and up-
date on global distribution of measles genotypes. Wkly Epidemiol 
Rec. 2005;80:347–51.
  8.   World Health Organization. Global reductions in measles mortal-
ity 2000–2008 and the risk of measles resurgence. Wkly Epidemiol 
Rec. 2009;84:505–16.
  9.   Zhang Y, Zhu Z, Rota PA, Jiang X, Hu J, Wang J, et al. Molecu-
lar epidemiology of measles viruses in China, 1995–2003. Virol J. 
2007;4:14. DOI: 10.1186/1743-422X-4-14
10.   Zhang Y, Ji Y, Jiang X, Xu S, Zhu Z, Zheng L, et al. Genetic char-
acterization of measles viruses in China, 2004. Virol J. 2008;5:120. 
DOI: 10.1186/1743-422X-5-120
11.   Ji Y, Zhang Y, Xu S, Zhu Z, Zuo S, Jiang X, et al. Measles resurgence 
associated with continued circulation of genotype H1 viruses in Chi-
na, 2005. Virol J. 2009;6:135. DOI: 10.1186/1743-422X-6-135
12.   World Health Organization. Manual for the laboratory diagnosis of 
measles and rubella viral infection. 2nd ed. 2007 [cited 2010 Apr 8]. 
http://www.who.int/vaccines-documents
13.   Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. Measles 
viruses on throat swabs from measles patients use signaling lym-
phocytic activation molecule (CDw150) but not CD46 as a cellular 
receptor. J Virol. 2001;75:4399–401. DOI: 10.1128/JVI.75.9.4399-
4401.2001
14.   Lifﬁ  ck SL, Thi Thoung N, Xu W, Li Y, Phoung Lien H, Bellini WJ, 
et al. Genetic characterization of contemporary wild-type measles 
viruses from Vietnam and the People’s Republic of China: identiﬁ  -
cation of two genotypes within clade H. Virus Res. 2001;77:81–7. 
DOI: 10.1016/S0168-1702(01)00268-4
15.   Chibo D, Riddell M, Catton M, Lyon M, Lum G, Birch C. Studies 
of measles viruses circulating in Australia between 1999 and 2001 
reveals a new genotype. Virus Res. 2003;91:213–21. DOI: 10.1016/
S0168-1702(02)00273-3
16.   Bellini WJ, Rota PA. Genetic diversity of wild-type measles viruses: 
implications for global measles elimination programs. Emerg Infect 
Dis. 1998;4:29–35. DOI: 10.3201/eid0401.980105
17.   Rota JS, Rota PA, Redd SB, Redd SC, Pattamadilok S, Bellini WJ. 
Genetic analysis of measles viruses isolated in the United States, 
1995–1996. J Infect Dis. 1998;177:204–8. DOI: 10.1086/513825
18.   World Health Organization. Expanded Programme on Immunization 
(EPI). Standardization of the nomenclature for describing the ge-
netic characteristics of wild-type measles viruses. Wkly Epidemiol 
Rec. 1998;73:265–72.
19.   Rota PA, Lifﬁ  ck SL, Rota JS, Katz RS, Redd S, Papania M, et al. 
Molecular epidemiology of measles viruses in the United States, 
1997–2001. Emerg Infect Dis. 2002;8:902–8.
20.   Rota PA, Bellini WJ. Update on the global distribution of geno-
types of wild-type measles viruses. J Infect Dis. 2003;187(Suppl 
1):S270–6. DOI: 10.1086/368042
21.   World Health Organization. WHO regional EPI targets: eliminate 
measles and control hepatitis B by 2012. Fifty-sixth session of 
the WHO Regional Committee for the Western Paciﬁ  c; 2005 Sep 
19–23; Noumea, New Caledonia. Press release [cited 2010 Apr 
8]. http://www.wpro.who.int/rcm/en/archives/rc56/press_releases/
pr_20050922+RCM.htm
Address for correspondence: Wenbo Xu, National Institute for Viral 
Disease Control and Prevention, Chinese Center for Disease Control and 
Prevention, Rm 509, 27 Nan Wei Rd, Xuan Wu District, Beijing, China 
100050; email: wenbo_xu1@yahoo.com.cn
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 6, June 2010  947 
All material published in Emerging Infectious Diseases is in the 
public domain and may be used and reprinted without special 
permission; proper citation, however, is required.
Use of trade names is for identiﬁ  cation only and does not imply 
endorsement by the Public Health Service or by the U.S. 
Department of Health and Human Services.